| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.90B | 4.34B | 4.12B | 4.02B | 10.31B | 11.55B |
| Gross Profit | 2.02B | 2.89B | 2.83B | 2.95B | 7.29B | 8.22B |
| EBITDA | -3.28B | 987.90M | 951.90M | 1.27B | 3.65B | 4.36B |
| Net Income | -1.98B | 1.59B | -4.05B | 1.47B | 13.43B | -1.63B |
Balance Sheet | ||||||
| Total Assets | 25.39B | 25.44B | 42.09B | 42.90B | 46.92B | 59.09B |
| Cash, Cash Equivalents and Short-Term Investments | 1.67B | 2.15B | 3.64B | 4.35B | 3.18B | 2.93B |
| Total Debt | 9.23B | 9.85B | 10.23B | 15.55B | 16.19B | 16.38B |
| Total Liabilities | 12.43B | 12.90B | 23.08B | 20.32B | 21.32B | 45.79B |
| Stockholders Equity | 12.74B | 12.37B | 19.06B | 22.44B | 25.93B | 13.66B |
Cash Flow | ||||||
| Free Cash Flow | 1.20B | 1.12B | 1.24B | 1.95B | 2.14B | 2.89B |
| Operating Cash Flow | 1.37B | 2.03B | 2.17B | 2.84B | 3.55B | 4.19B |
| Investing Cash Flow | -258.00M | 684.70M | -1.84B | 1.28B | -5.80B | -8.87B |
| Financing Cash Flow | -1.87B | -2.25B | -692.40M | -3.28B | -1.55B | 1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $4.63B | 9.04 | 25.22% | 7.78% | 0.59% | 8.86% | |
75 Outperform | $3.64B | 5.64 | 48.17% | ― | 6.42% | ― | |
61 Neutral | $5.23B | -33.32 | -2.95% | 0.40% | 15.38% | -292.52% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | $4.38B | -37.59 | 1.73% | 0.39% | -22.79% | 79.90% | |
55 Neutral | $7.97B | -4.69 | ― | ― | -4.56% | 23.46% | |
51 Neutral | $3.78B | -1.00 | ― | ― | ― | ― |